Identification of the IFITM Family As a New Molecular Marker in Human Colorectal Tumors

Identification of the IFITM Family As a New Molecular Marker in Human Colorectal Tumors

Research Article Identification of the IFITM Family as a New Molecular Marker in Human Colorectal Tumors Pauline Andreu,1 Sabine Colnot,1 Ce´cile Godard,1 Pierre Laurent-Puig,2 Dominique Lamarque,3 Axel Kahn,1 Christine Perret,1 and Be´atrice Romagnolo1 1Institut Cochin, INSERM U567, Centre National de la Recherche Scientifique UMR8104, Universite´Paris V; 2Universite´Paris-Descartes, INSERM, AP-HP, UFR des Sts Pe`resUMR-S490 Laboratoire de Toxicologie Mole´culaire; and 3Unite´d’He´pato-Gastroente´rologie,Hotel-Dieu, Notre Dame, Paris, France Abstract diagnosis. It is well established that one of the initiating steps in We analyzed the expression profiles of intestinal adenomas colorectal carcinogenesis is a mutation in the APC tumor from a new murine familial adenomatous polyposis model suppressor gene. APC mutations, which generally lead to a # f (Apc 14/+) using suppression subtractive hybridization to truncated protein, have been detected in 80% of sporadic cancers and cause familial adenomatous polyposis (FAP; ref. 8). identify novel diagnostic markers of colorectal carcinogenesis. h We identified 18 candidate genes having increased expression APC binds to -catenin and regulates the activation of the Wnt/ h-catenin pathway. Activation of the Wnt pathway leads to the levels in the adenoma. Subsequent Northern blotting, real- h time reverse transcription-PCR, and in situ hybridization association of -catenin with the Tcf/lef transcription factors (9). analysis confirmed their induction in B-catenin-activated This complex can activate the transcription of a variety of target genes. Loss of Apc function leads to an abnormal accumulation of epithelial cells of murine adenomas. We showed that most of h the genes also have altered expression levels in human colonic -catenin and dysregulated Wnt signaling. adenomas and carcinomas. We focused on the IFITM genes Therefore, we have examined the expression of the deregulated genes in adenomas developed in a murine model of FAP that we that encode IFN-inducible transmembrane proteins. Serial D14/+ analyses of gene expression levels revealed high levels of have recently established, Apc , to identify targets critical for expression in early and late intestinal neoplasm in both mice the initiation of cancer. These mice carry an Apc germ line and humans. Using a conditional mouse model of Apc mutation that leads to numerous adenomas developing in both the inactivation and a human colon carcinoma cell line, we small and large intestine (10). The phenotypic similarity with showed that IFITM gene expression is rapidly induced after human colon adenoma development makes this a useful mouse activation of the B-catenin signaling. Using a large-scale model system to investigate the molecular mechanisms leading to analysis of human tumors, we showed that IFITM gene adenoma formation. We used a suppression subtractive hybridiza- expression is significantly up-regulated specifically in colo- tion (SSH) library approach to characterize the changes in gene rectal tumors and thus may be a useful diagnostic tool in these expression that accompany the progression from normal murine intestinal epithelia to adenomas. We checked the relevance of the tumors. (Cancer Res 2006; 66(4): 1949-55) identified genes in human colon adenomas and carcinomas. Here, we report several candidate genes in which expression levels are Introduction altered in adenomatous polyps from both mice and humans. We Colon cancer is triggered by a series of point mutations and focused on the IFN-inducible transmembrane gene family (IFITM). genetic alterations that progressively cause normal cells to Using different mouse models of Apc inactivation and human transform into adenomas that could become progressively more colon tumor samples, we have established that expression of dysplastic, resulting in carcinoma foci (1). The genetic alterations several members of the IFITM family was up-regulated in early might occur in a preferred sequence and could determine the and late intestinal neoplasms. We present evidence that the up- clinical characteristics of the colorectal tumor. Large-scale regulation of the IFITM genes seems to be an early event in screening of gene expression profiles of colon cancers, using h-catenin intestinal tumorigenesis. Finally, we have shown by methods such as cDNA microarrays or serial analysis of gene analyzing various distinct types of human tumors and their expression reverse transcription-PCR, have identified many of corresponding non–tumor tissue that IFITM genes are specifically these alterations (2–7). However, the screening of carcinomas induced in colorectal tumors and thus may provide a new cannot distinguish changes in gene expression that are critical to diagnostic marker in these tumors. the initiation of tumorigenesis. Identification of genes induced early in the first step of tumorigenesis is important both for a better understanding of the biological processes leading to cancer Materials and Methods development and for identifying novel molecular markers for Animals and treatment. All experiments involving mice were carried out in accordance with French government regulations. The generation of ApcD14/+ and Apclox/loxvil-CreERT2 mice has been previously described (10, 11). In Apclox/loxvil-CreERT2 mice, the Cre recombinase was activated by Note: Supplementary data for this article are available at Cancer Research Online a single injection of tamoxifen solution (1 mg; Sigma, St. Louis, MO). Four (http://cancerres.aacrjournals.org/). days after tamoxifen injection, the mice were killed and the intestines were Requests for reprints: Christine Perret, Institut Cochin, 24 rue du Fb St-Jacques, collected. 75014 Paris, France. Phone: 33-1-4441-2564; Fax: 33-1-4441-2421; E-mail: perret@ Suppression subtractive hybridization. Male wild-type and ApcD14/+ cochin.inserm.fr. I2006 American Association for Cancer Research. mice were killed at 5 months old. We harvested 20 adenomas from the doi:10.1158/0008-5472.CAN-05-2731 duodenum and colon of six ApcD14/+ mice. Normal duodenum and colon www.aacrjournals.org 1949 Cancer Res 2006; 66: (4). February 15, 2006 Downloaded from cancerres.aacrjournals.org on October 2, 2021. © 2006 American Association for Cancer Research. Cancer Research tissues were harvested from wild-type mice. Total RNA and mRNA samples serum and 0.6 mg/mL hygromycin B solution at 37jC in a humidified h from murine adenomas and wild-type tissues were isolated with Trizol 5% CO2 atmosphere. HT29-APC and HT29- -gal cultures were treated with + reagent (Invitrogen, San Diego, CA) and a poly(A ) mRNA isolation kit 120 mmol/L ZnCl2 for 24 hours and total RNA was extracted from (Ambion, Austin, TX) according to the manufacturer’s protocol. Subtractive the lysates. hybridization with mRNA samples from tumor-bearing intestine and normal intestine, and subsequent differential screening were carried out Results using the PCR-Select cDNA subtraction kit and the PCR-Select differential screening kit (Clontech, Palo Alto, CA), according to the manufacturer’s Identification of genes overexpressed in adenomas from #14/+ protocols. For each subtracted cDNA library (duodenum and colon) f4,000 small and large intestine from Apc mice. We have D14/+ clones were plated and 96 recombinant clones for each library were previously developed a new germ line Apc mouse model in randomly picked and sequenced. BLAST search of the gene database was which the Apc exon 14 is deleted (10). Like other FAP mouse used to analyze sequence homologies. models, polyps develop after the wild-type Apc allele is lost (loss of Northern blotting. Experimental samples for Northern blotting were heterozygosity). Unlike other Apc+/À mouse models in which D14/+ collected from Apc mice and wild-type mice. Total RNA was isolated tumors developed mainly in the small intestine, these mice using Trizol (Invitrogen). For each sample, 10 Ag of total RNA was developed many polyps in both the small intestine and the colon. electrophoresed through 1% agarose-6% formaldehyde gel. The RNAs were Therefore, this mouse model has allowed us to determine the gene transferred to Hybond N+ membranes and hybridized with the 32 expression profile of adenomas in the small and the large intestine. corresponding P-labeled probes. In situ hybridization. Immediately after killing the mouse, the entire We harvested 20 adenomas and normal tissue from both the small gastrointestinal tract was removed, splayed open along its length, fixed in intestine and the distal colon. We used SSH to identify genes that 10% formol and then rolled up from the proximal to distal end to form were overexpressed in adenomas compared with normal adult a Swiss roll. In situ hybridization was carried out on 7 Am slices of the tissue. We isolated 18 distinct genes in the adenomatous tissues paraffin-embedded Swiss rolls. SSH library clones were subcloned in (Table 1). We isolated a set of Paneth cell markers (Mmp7, Lyzs, PGEMT. Digoxigenin-labeled RNA probes were prepared by in vitro Pla2g2a, and Defcr1 genes). In a previous study, we showed that transcription with the digoxigenin RNA labeling kit (Roche, Meylan, France) Paneth cell markers are induced in murine and human intestinal using T7 or Sp6 RNA polymerases. Sections were incubated overnight at neoplasia (11). These findings have been recently confirmed by j 68 C in the prehybridization buffer containing 200 ng/mL of digoxigenin- another study (13). In the present study, we did not carry out any labeled RNA probe. Immunodetection

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    8 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us